Andreas Friedl
Impact in
- Cell Biology top 0.5%
- Proteoglycans and glycosaminoglycans research
- Cellular Mechanics and Interactions
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments
Papers in
- Cell Biology 15
- Proteoglycans and glycosaminoglycans research 14
-
- Breast Cancer Treatment Studies 3
- Co-authors
- Carolyn A. Pehlke (4 shared papers)Kevin W. Eliceiri (5 shared papers)Jens Eickhoff (4 shared papers)Patricia J. Keely (4 shared papers)Kristy K. Meyer (10 shared papers)Matthew W. Conklin (3 shared papers)Paolo P. Provenzano (1 shared paper)Kristin M. Riching (1 shared paper)
- Journals
- Cancer Research (6 papers)American Journal Of Pathology (5 papers)Journal of Biological Chemistry (4 papers)Breast Cancer Research and Treatment (3 papers)PLoS ONE (3 papers)
- Partner nations
- United StatesGermanyTürkiye
In The Last Decade
Andreas Friedl
63 papers receiving 5.5k citations
Andreas Friedl's Hit Papers
Peers
Comparison fields: 5 of 82
- Cell Biology 1.1k
- Transplantation 218
- Oncology 370
- Cancer Research 198
- Immunology and Allergy 76
Countries citing papers authored by Andreas Friedl
This map shows the geographic impact of Andreas Friedl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Friedl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Friedl more than expected).
Fields of papers citing papers by Andreas Friedl
This network shows the impact of papers produced by Andreas Friedl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Friedl. The network helps show where Andreas Friedl may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Friedl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma Hit paper breakdown → | 2011 | 1066 |
| 2 | 2003 | 330 | |
| 3 | 2010 | 204 | |
| 4 | 2007 | 192 | |
| 5 | 2003 | 191 | |
| 6 | 2012 | 187 | |
| 7 | Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. | 2000 | 157 |
| 8 | 1998 | 143 | |
| 9 | 2010 | 143 | |
| 10 | 2009 | 139 | |
| 11 | 2005 | 136 | |
| 12 | 2002 | 134 | |
| 13 | 2006 | 131 | |
| 14 | 2011 | 127 | |
| 15 | 2006 | 125 | |
| 16 | 2013 | 124 | |
| 17 | 2004 | 118 | |
| 18 | 2005 | 117 | |
| 19 | 2017 | 114 | |
| 20 | 2003 | 106 |
About Andreas Friedl
Andreas Friedl is a scholar working on Cell Biology, Cancer Research, Oncology, Molecular Biology and Transplantation, having authored 64 papers that have together received 5.6k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (14 papers), Angiogenesis and VEGF in Cancer (6 papers), Estrogen and related hormone effects (4 papers), Cancer Cells and Metastasis (3 papers), Fibroblast Growth Factor Research (3 papers), Breast Cancer Treatment Studies (3 papers), Prostate Cancer Treatment and Research (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). The work is most often cited by research in Cell Biology (1.1k citations), Transplantation (218 citations), Oncology (370 citations), Cancer Research (198 citations) and Immunology and Allergy (76 citations). Andreas Friedl has collaborated with scholars based in United States, Germany and Türkiye. Frequent co-authors include Carolyn A. Pehlke, Kevin W. Eliceiri, Jens Eickhoff, Patricia J. Keely, Kristy K. Meyer, Matthew W. Conklin, Paolo P. Provenzano, Kristin M. Riching, David J. Beebe and Christoph Mundhenke. Their work appears in journals such as Cancer Research, American Journal Of Pathology, Journal of Biological Chemistry, Breast Cancer Research and Treatment and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.